SaferWorldbyDesign Webinar: Use of alternative skin models for animal-free safety and efficacy testing in dermatology research

Tuesday 11 August 2020

16-16:45 CEST - (7 am California, 10 am New York, 3 pm London, 4 pm Zurich, 7:30 pm New Delhi, 11 pm Tokyo)

This virtual meeting will include a perspective by Hanan Osman-Ponchet (Founder & President, PKDERM) followed by a discussion session.

A set of alternative in vitro and ex vivo skin models can be used to evaluate the safety and efficacy of topical products. For example, 2D-cell culture derived from human skin can be used to evaluate anti-inflammatory, anti-aging, skin pigmentation, wound healing, or to predict skin sensitization of active molecules. On the other hand, 3D-human reconstructed skin models can be used to evaluate skin irritation (safety), skin sensitization (safety), or even anti-inflammatory properties (efficacy) of topical products. Excised human skin model, on the other hand, is used as the gold standard to evaluate dermal absorption, skin metabolism, and drug transporters, since dermal absorption data are of importance in toxicological risk assessment.

But what is the most appropriate skin model to be used for specific assessment of safety and efficacy in dermatology based on the development stage?

In this webinar, an overview of the in vitro alternative skin models will be presented with practical examples on the advantages and limitations of each model in safety and efficacy assessment, with a focus on dermal absorption and inflammation testing.

Latest Tweets

Edelweiss Connect (Yesterday)
The goal of this webinar and discussion is to provide insight into the combined use of in silico and in vitro evide… https://t.co/W3hE1Cm95K
Edelweiss Connect (Yesterday)
#SaferWorldbyDesign presents: Skin safety assessment according to OECD guidelines Join us on December 17 for a we… https://t.co/oGymiPDVp0
Edelweiss Connect (2 days ago)
JRC Data Visualization: Extrapolating from acute to chronic toxicity in vitro An important question that was addre… https://t.co/B5Ius3qtDk
Edelweiss Connect (2 days ago)
#SaferWorldbyDesign webinar: In Silico solutions for drug discovery Presented by @Maieutix1 #insilico… https://t.co/Ya5J0ySQ0Q
Edelweiss Connect (2 weeks ago)
See why @wepredic @Biopredic_Intl #HepaRG™ cell model is the best for NAFLD investigations #SaferWorldbyDesign… https://t.co/pzgJbUhY7d

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA